U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Search Results

Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine
Status: Currently in Shortage
»Date first posted: 02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric

Expand all

Fresenius Kabi USA, LLC (Revised 03/10/2023)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17) Backordered. Next release April 2023. Check wholesalers for inventory. Manufacturing delay
Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17) Backordered. Next release not available at this time. Manufacturing delay
Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17) Backordered. Next release not available at this time. Check wholesalers for inventory. Manufacturing delay
Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17) Backordered. Next release not available at this time. Check wholesalers for inventory. Manufacturing delay

Hospira, Inc., a Pfizer company (Revised 03/17/2023)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01) Next Delivery: March 2023; Estimated Recovery: September 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01) Next Delivery: June 2023; Estimated Recovery: December 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02) Next Delivery: March 2023; Estimated Recovery: March 2024 Demand increase for the drug
500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03) Next Delivery: September 2023; Estimated Recovery: March 2024 Demand increase for the drug
75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01) Next Delivery: July 2023; Estimated Recovery: March 2024 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01) Next Delivery and Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01) Next Delivery: March 2023; Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02) Next Delivery: April 2023; Estimated Recovery: December 2023 Demand increase for the drug
1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03) Next Delivery: March 2023; Estimated Recovery: December 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01) Next Delivery: March 2023; Estimated Recovery: June 2023 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
Back to Top